Method for achieving desired glial growth factor 2 plasma...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/28 (2006.01)

Patent

CA 2717193

The present invention relates to administering glial growth factor 2 (GGF2) to a patient in need thereof, to achieve serum levels of GGF2 within a desired therapeutic window determined based on the dis-ease or disorder afflicting the patient. In a particular embodiment, the pa-tient is suffering from a disease or disorder associated with reduced levels of myelination and the GGF2 is administered to promote myelination in the patient.

La présente invention concerne l'administration du facteur de croissance gliale 2 (GGF2) à un patient nécessitant un tel traitement, en vue d'atteindre des concentrations plasmiques de GGF2 situées dans une zone thérapeutique désirée, déterminée en fonction de la maladie ou du trouble affectant le patient. Dans un mode de réalisation particulier, le patient est atteint d'une maladie ou d'un trouble associé à des niveaux réduits de myélinisation et le GGF2 est administré pour favoriser la myélinisation chez le patient.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method for achieving desired glial growth factor 2 plasma... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for achieving desired glial growth factor 2 plasma..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for achieving desired glial growth factor 2 plasma... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1647289

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.